Vaxcyte definition
Examples of Vaxcyte in a sentence
This Seventh Amendment is to be incorporated as part of the Development and Manufacturing Agreement, dated October 21, 2016, between Lonza and Vaxcyte (at that time known as SutroVax, Inc.), as amended from time to time (the “Original Agreement”).
Vaxcyte and Lonza hereby enter into this Eighth Amendment, effective as of the Eighth Amendment Effective Date.
The addresses and e-mail addresses for such communications shall be: If to the Company: Vaxcyte, Inc.
The cash flows were estimated for a 5-year period based on TASE’s operating results for the first half of 2017 and management’s forecast for the second half of 2017 and subsequent years, and on additional assumptions.
This Ninth Amendment is to be incorporated as part of the Development and Manufacturing Services Agreement, dated October 21, 2016, between Lonza and Vaxcyte (at that time known as SutroVax, Inc.), as amended from time to time (the “Original Agreement”).
Vaxcyte shall not file (and shall prohibit its Affiliates, Approved CMOs and Approved Contractors from filing) any Patents claiming [***] IP or Jointly-Owned IP, and Vaxcyte will reasonably cooperate with Sutro in connection with any filings for such Patents.
This Eighth Amendment is to be incorporated as part of the Development and Manufacturing Services Agreement, dated October 21, 2016, between Lonza and Vaxcyte (at that time known as SutroVax, Inc.), as amended (the “Original Agreement”).
Vaxcyte and Lonza hereby enter into this Ninth Amendment, effective as of the Ninth Amendment Effective Date.
Janet Graesser, Vice President, Corporate Communications and Investor Relations Vaxcyte, Inc.
By: /s/ Xxxxxx Xxxxxx Name Xxxxxx Xxxxxx Title Date 13-Apr-2022 By: /s/ Xxxxx Xxxxxx Name Xxxxx Xxxxxx Title Date 13-Apr-2022 By: /s/ Xxxxx Xxxxxxxxx Name Xxxxx Xxxxxxxxx Title CEO Date 4/12/2022 CONFIDENTIAL This First Amendment (the “First Amendment”), comes into effect on May 12, 2022 (the “First Amendment Effective Date”), is made by and between Lonza Ltd (“Lonza”) and Vaxcyte, Inc.